These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3632139)

  • 1. Evidence for a class 4 effect of cibenzoline "in vivo".
    Sassine A; Massé C; Brugada J; Romero-Ayala LC; Canovas M; Cazes M; Puech P
    Arch Int Pharmacodyn Ther; 1987 May; 287(1):78-88. PubMed ID: 3632139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dog.
    Sassine A; Massé C; Dufour A; Hirsch JL; Cazes M; Puech P
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):201-18. PubMed ID: 6476979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Sep; 77(9):595-9. PubMed ID: 3195178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.
    Millar JS; Vaughan Williams EM
    Br J Pharmacol; 1982 Mar; 75(3):469-78. PubMed ID: 7066601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of cibenzoline on normal myocardium and after pretreatment with DL-sotalol.
    Beyer ME; Hoffmeister HM; Seipel L
    J Cardiovasc Pharmacol; 1992 May; 19(5):657-64. PubMed ID: 1381761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs.
    Nakayama K; Oshima T; Koike H
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):145-56. PubMed ID: 6121536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction by carbachol of ventricular conduction impairments induced by various class I antiarrhythmic drugs in anesthetized dogs.
    de la Coussaye JE; Bassoul B; Bruelle P; Peray PA; Albat B; Gagnol JP; Daures JP; Eledjam JJ; Sassine A
    Arch Int Pharmacodyn Ther; 1992; 315():47-62. PubMed ID: 1417363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
    Millar JS; Vaughan Williams EM
    Br J Pharmacol; 1983 Jul; 79(3):701-9. PubMed ID: 6652350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
    Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
    Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of isoproterenol and propranolol on pharmacologically induced depression of intraventricular conduction.
    Lang J; Timour Q; Lancon JP; Aupetit JF; Bertrix L; Faucon G
    Fundam Clin Pharmacol; 1989; 3(3):281-94. PubMed ID: 2767608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressant effect on the retrograde atrioventricular nodal conduction of beta-adrenergic blockade by propranolol in humans.
    Shenasa M; Lacombe P; Côté MA; Sadr-Ameli MA; Nadeau R
    Can J Cardiol; 1987 Sep; 3(6):281-7. PubMed ID: 3427528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac electrophysiologic actions of KB-944 (Fostedil), a new calcium antagonist, in the anesthetized dog.
    Patterson E; Montgomery DG; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):632-40. PubMed ID: 6540806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.